Research output per year
Research output per year
Fingerprint
Dive into the research topics where V.A.S.H. Dalm is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes
Milito, C., Firinu, D., Bez, P., Villa, A., Punziano, A., Lagnese, G., Costanzo, G., van Leeuwen, L. P. M., Piazza, B., Deiana, C. M., d’Ippolito, G., Del Giacco, S. R., Rattazzi, M., Spadaro, G., Quinti, I., Scarpa, R., Dalm, V. A. S. H. & Cinetto, F., 8 Feb 2023, In: Frontiers in Immunology. 14, 1093385.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
Geers, D., Sablerolles, R. S. G., SWITCH Research Group, van Baarle, D., Kootstra, N. A., Rietdijk, W. J. R., Schmitz, K. S., Gommers, L., Bogers, S., Nieuwkoop, N. J., van Dijk, L. L. A., van Haren, E., Lafeber, M., Dalm, V. A. S. H., Goorhuis, A., Postma, D. F., Visser, L. G., Huckriede, A. L. W., Sette, A., Grifoni, A., & 5 others, 20 Jan 2023, In: iScience. 26, 1, 105753.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)30 Downloads (Pure) -
A germline STAT6 gain-of-function variant is associated with early-onset allergies
Suratannon, N., Ittiwut, C., Dik, W. A., Ittiwut, R., Meesilpavikkai, K., Israsena, N., Ingrungruanglert, P., Dalm, V. A. S. H., van Daele, P. L. A., Sanpavat, A., Chaijitraruch, N., Schrijver, B., Buranapraditkun, S., Porntaveetus, T., Swagemakers, S. M. A., IJspeert, H., Palaga, T., Suphapeetiporn, K., van der Spek, P. J., Hirankarn, N., & 3 others, Feb 2023, In: Journal of Allergy and Clinical Immunology. 151, 2, p. 565-571.e9Research output: Contribution to journal › Article › Academic › peer-review
6 Citations (Scopus) -
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome
Rao, V. K., Webster, S., Šedivá, A., Plebani, A., Schuetz, C., Shcherbina, A., Conlon, N., Coulter, T., Dalm, V. A., Trizzino, A., Zharankova, Y., Kulm, E., Körholz, J., Lougaris, V., Rodina, Y., Radford, K., Bradt, J., Kucher, K., Relan, A., Holland, S. M., & 2 others, 2 Mar 2023, In: Blood. 141, 9, p. 971-983 13 p.Research output: Contribution to journal › Article › Academic › peer-review
3 Citations (Scopus) -
Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study
Malahe, S. R. K., Hoek, R. A. S., Dalm, V. A. S. H., Broers, A. E. C., den Hoed, C. M., Manintveld, O. C., Baan, C. C., van Deuzen, C. M., Papageorgiou, G., Bax, H. I., Van Kampen, J. J., Hellemons, M. E., Kho, M. M. L., de Vries, R. D., Molenkamp, R., Reinders, M. E. J. & Rijnders, B. J. A., 1 Feb 2023, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 76, 3, p. e172-e178 ciac571.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile15 Citations (Scopus)13 Downloads (Pure)